News for TIS Inc. (3626.T)

CHMP Recommends Approval of Galderma's Nemolizumab for Moderate-to-Severe Atopic Dermatitis and Prurigo Nodularis in the European Union

The Fund returned 7.52% versus 6.36% for the MSCI World Index for the quarter, and 9.36% since inception versus 6.42% for the index over the same period.

Insightful Analysis of Portfolio Adjustments and Market Strategy Oakmark Intl Small Cap (Trades, Portfolio), known for its strategic investments in small cap c

Oakmark International Small Cap Fund returned -3.11% versus -1.56% for the MSCI World ex USA Small Cap Index (Net) for the quarter. Click here for the commentary.

Insightful Analysis of Oakmark Intl Small Cap (Trades, Portfolio)'s Latest Strategic Portfolio Adjustments Oakmark Intl Small Cap (Trades, Portfolio), known fo

Harris Associates International Small Cap Strategy portfolio’s return was 0.65% (net) for the reporting period. Click here to read the full letter.

The Oakmark International Small Cap Fund returned 0.51% for the quarter ending March 31, underperforming the benchmark, which returned 2.58% for the same period.

The Oakmark International Small Cap Fund (”œthe Fund”) returned 0.51% for the quarter ending March 31, underperforming the benchmark, the MSCI World ex USA S

June 9, 2023 News Release Company name: ... | June 9, 2023

Vector Consulting Group A Leading Management Consulting Firm In India Announces Capital And Business Alliance With TIS Inc One Of The Largest Tech Firms In Japan